HK1067645A1 - Tumor antigen peptides originating in cyclophilin b - Google Patents
Tumor antigen peptides originating in cyclophilin bInfo
- Publication number
- HK1067645A1 HK1067645A1 HK04109605A HK04109605A HK1067645A1 HK 1067645 A1 HK1067645 A1 HK 1067645A1 HK 04109605 A HK04109605 A HK 04109605A HK 04109605 A HK04109605 A HK 04109605A HK 1067645 A1 HK1067645 A1 HK 1067645A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tumor antigen
- antigen peptides
- cyclophilins
- cyclophilin
- derivatives
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 239000000427 antigen Substances 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 102100040283 Peptidyl-prolyl cis-trans isomerase B Human genes 0.000 title 1
- 108010048032 cyclophilin B Proteins 0.000 title 1
- 108010044156 peptidyl-prolyl cis-trans isomerase b Proteins 0.000 title 1
- 102000001493 Cyclophilins Human genes 0.000 abstract 4
- 108010068682 Cyclophilins Proteins 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17844998 | 1998-06-25 | ||
| PCT/JP1999/003360 WO1999067288A1 (fr) | 1998-06-25 | 1999-06-24 | Peptides d'antigenes tumoraux provenant de la cyclophiline b |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1067645A1 true HK1067645A1 (en) | 2005-04-15 |
Family
ID=16048723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04109605A HK1067645A1 (en) | 1998-06-25 | 2004-12-03 | Tumor antigen peptides originating in cyclophilin b |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7041297B1 (xx) |
| EP (1) | EP1090924B8 (xx) |
| JP (1) | JP4413429B2 (xx) |
| KR (1) | KR100653590B1 (xx) |
| CN (1) | CN1318447C (xx) |
| AT (1) | ATE375362T1 (xx) |
| AU (1) | AU749544B2 (xx) |
| CA (1) | CA2331761A1 (xx) |
| DE (1) | DE69937294T2 (xx) |
| ES (1) | ES2294844T3 (xx) |
| HK (1) | HK1067645A1 (xx) |
| ID (1) | ID27788A (xx) |
| NZ (1) | NZ508996A (xx) |
| TW (1) | TWI228128B (xx) |
| WO (1) | WO1999067288A1 (xx) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105306B1 (en) * | 2000-08-10 | 2006-09-12 | Trustees Of The University Of Pennsylvania | Methods and compositions for modulating somatolactogenic functions |
| EP1212078B1 (en) * | 1999-09-10 | 2005-06-22 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Ant-1 as drug target |
| US6833365B2 (en) * | 2000-01-24 | 2004-12-21 | Trustees Of Tufts College | Tetracycline compounds for treatment of Cryptosporidium parvum related disorders |
| DE60102815D1 (de) * | 2000-05-15 | 2004-05-19 | Paratek Pharm Innc | 7-substituierte kondensierte ring-tetrazyclin- verbindungen |
| AU2001268475A1 (en) * | 2000-06-16 | 2002-01-02 | Trustees Of Tufts College | 7-phenyl-substituted tetracycline compounds |
| WO2003055441A2 (en) * | 2001-08-02 | 2003-07-10 | Paratek Pharmaceuticals, Inc. | Medicaments |
| DK2267021T3 (en) | 2002-09-12 | 2015-03-30 | Oncotherapy Science Inc | KDR peptides and vaccines comprising the same |
| CA2538300A1 (en) * | 2003-09-22 | 2005-03-31 | Green Peptide Co., Ltd. | Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent |
| TWI261038B (en) * | 2004-08-11 | 2006-09-01 | Bo-Cheng Chen | Bicycle gear-shifting handgrip |
| EP2301916A3 (en) | 2004-10-25 | 2011-09-28 | Paratek Pharmaceuticals, Inc. | 4-aminotetracyclines and methods of use thereof |
| AU2007244153C1 (en) | 2006-05-01 | 2011-09-29 | Hitachi Chemical Company, Ltd. | Prostasin partial peptide and anti-prostasin antibody |
| WO2008045507A2 (en) | 2006-10-11 | 2008-04-17 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of bacillus anthracis infections |
| TW200831673A (en) | 2006-12-13 | 2008-08-01 | Oncotherapy Science Inc | TTK as tumor marker and therapeutic target for lung cancer |
| JP5470558B2 (ja) | 2007-02-16 | 2014-04-16 | オンコセラピー・サイエンス株式会社 | 脈絡膜新生血管のワクチン療法 |
| TWI434853B (zh) | 2007-04-11 | 2014-04-21 | Oncotherapy Science Inc | 腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗 |
| US20110160280A1 (en) | 2007-08-24 | 2011-06-30 | Oncotherapy Science, Inc. | Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| CN101854945B (zh) | 2007-09-18 | 2015-07-01 | 株式会社绿多肽 | Ctl诱导剂组合物 |
| ES2388958T3 (es) | 2007-11-29 | 2012-10-22 | Actelion Pharmaceuticals Ltd. | Derivados de acido fosfonico y su uso como antagonista del receptor P2Y12 |
| TWI526219B (zh) | 2008-06-19 | 2016-03-21 | 腫瘤療法 科學股份有限公司 | Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗 |
| DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
| TWI500932B (zh) | 2008-12-05 | 2015-09-21 | Oncotherapy Science Inc | Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗 |
| TWI469791B (zh) | 2009-02-18 | 2015-01-21 | Oncotherapy Science Inc | Ｆｏｘｍ１胜肽以及含此胜肽之疫苗 |
| CN102356155B (zh) | 2009-03-18 | 2016-02-24 | 肿瘤疗法科学股份有限公司 | Neil3肽及包含它的疫苗 |
| TWI507204B (zh) | 2009-05-26 | 2015-11-11 | Oncotherapy Science Inc | Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗 |
| TW201136604A (en) | 2009-12-14 | 2011-11-01 | Oncotherapy Science Inc | TMEM22 peptides and vaccines including the same |
| RU2570560C2 (ru) | 2010-03-11 | 2015-12-10 | Онкотерапи Сайенс, Инк. | Пептиды hjurp и содержащие их вакцины |
| WO2013018690A1 (ja) | 2011-07-29 | 2013-02-07 | 国立大学法人徳島大学 | Erap1由来ペプチド及びその使用 |
| US9458447B2 (en) | 2011-08-12 | 2016-10-04 | Oncotherapy Science, Inc. | MPHOSPH1 peptides and vaccines including the same |
| BR112014009176B1 (pt) | 2011-10-28 | 2022-08-30 | Oncotherapy Science, Inc | Composição para indução de linfócito t citotóxico (ctl), uso no tratamento e profilaxia de câncer e indução de resposta imune contra câncer e métodos in vitro para indução de ctl |
| US9561265B2 (en) | 2012-07-10 | 2017-02-07 | Oncotherapy Science, Inc. | KIF20A epitope peptides for TH1 cells and vaccines containing the same |
| JP6255594B2 (ja) | 2012-07-10 | 2018-01-10 | オンコセラピー・サイエンス株式会社 | Ｔｈ１細胞のＬＹ６Ｋエピトープペプチドおよびこれを含有するワクチン |
| WO2014041784A1 (en) | 2012-09-11 | 2014-03-20 | Oncotherapy Science, Inc. | Ube2t peptides and vaccines containing the same |
| TWI658049B (zh) | 2013-03-12 | 2019-05-01 | 腫瘤療法 科學股份有限公司 | Ｋｎｔｃ２胜肽及含此胜肽之疫苗 |
| SG11201603165TA (en) | 2013-10-21 | 2016-05-30 | Taiho Pharmaceutical Co Ltd | Novel Peptide Having 4 Linked CTL Epitopes |
| MX2017001650A (es) | 2014-08-04 | 2017-04-27 | Oncotherapy Science Inc | Peptido derivado de cdca1 y vacuna que lo contiene. |
| CN111925413A (zh) | 2014-08-04 | 2020-11-13 | 肿瘤疗法科学股份有限公司 | Koc1衍生的肽和包含它们的疫苗 |
| ES2856834T3 (es) | 2014-08-04 | 2021-09-28 | Oncotherapy Science Inc | Péptido derivado de URLC10 y vacuna que contiene el mismo |
| EP4219525A3 (en) | 2015-10-08 | 2023-09-27 | OncoTherapy Science, Inc. | Foxm1-derived peptide, and vaccine including same |
| KR20240099456A (ko) | 2018-06-29 | 2024-06-28 | 다이호야쿠힌고교 가부시키가이샤 | 항종양제 및 그 평가방법 |
| TW202023581A (zh) | 2018-08-02 | 2020-07-01 | 日商腫瘤療法 科學股份有限公司 | 來自cdca1的胜肽及含有此的疫苗 |
| JP7525855B2 (ja) | 2018-11-30 | 2024-07-31 | 国立大学法人徳島大学 | Ｂｉｇ３－ｐｈｂ２相互作用阻害ｐｈｂ２由来ペプチドを含む乳がん治療薬 |
| AU2020411439A1 (en) | 2019-12-26 | 2022-08-04 | Taiho Pharmaceutical Co., Ltd. | Agent for adjuvant therapy |
| CN115078727A (zh) * | 2022-07-13 | 2022-09-20 | 首都医科大学附属北京胸科医院 | 一种预测癌症免疫治疗效果的标志物、试剂盒与应用 |
| DE102022118517A1 (de) | 2022-07-25 | 2024-01-25 | Dennis Reitmeir | Liegestützvorrichtung mit drehbaren Griffeinheiten |
| CN115372618A (zh) * | 2022-09-19 | 2022-11-22 | 首都医科大学附属北京胸科医院 | 一种检测蛋白标志物水平的试剂在制备用于评估肿瘤治疗效果的诊断产品中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0326067A3 (en) | 1988-01-26 | 1991-04-17 | The Du Pont Merck Pharmaceutical Company | Use of cyclophilin as an anti-inflammatory and immunomodulatory agent |
| AU4998993A (en) | 1992-08-07 | 1994-03-03 | Epimmune, Inc. | Hla binding peptides and their uses |
| JPH09151200A (ja) * | 1995-09-29 | 1997-06-10 | Ajinomoto Co Inc | ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤 |
| US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
-
1999
- 1999-06-24 CN CNB998098566A patent/CN1318447C/zh not_active Expired - Lifetime
- 1999-06-24 KR KR1020007014760A patent/KR100653590B1/ko not_active IP Right Cessation
- 1999-06-24 DE DE69937294T patent/DE69937294T2/de not_active Expired - Lifetime
- 1999-06-24 ID IDW20002735A patent/ID27788A/id unknown
- 1999-06-24 AU AU43926/99A patent/AU749544B2/en not_active Ceased
- 1999-06-24 EP EP99926783A patent/EP1090924B8/en not_active Expired - Lifetime
- 1999-06-24 CA CA002331761A patent/CA2331761A1/en not_active Abandoned
- 1999-06-24 NZ NZ508996A patent/NZ508996A/en unknown
- 1999-06-24 ES ES99926783T patent/ES2294844T3/es not_active Expired - Lifetime
- 1999-06-24 US US09/720,469 patent/US7041297B1/en not_active Expired - Fee Related
- 1999-06-24 JP JP2000555939A patent/JP4413429B2/ja not_active Expired - Lifetime
- 1999-06-24 AT AT99926783T patent/ATE375362T1/de not_active IP Right Cessation
- 1999-06-24 WO PCT/JP1999/003360 patent/WO1999067288A1/ja active IP Right Grant
- 1999-06-25 TW TW088110697A patent/TWI228128B/zh not_active IP Right Cessation
-
2004
- 2004-12-03 HK HK04109605A patent/HK1067645A1/xx not_active IP Right Cessation
-
2005
- 2005-09-16 US US11/227,238 patent/US7368107B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU749544B2 (en) | 2002-06-27 |
| ATE375362T1 (de) | 2007-10-15 |
| US7368107B2 (en) | 2008-05-06 |
| DE69937294D1 (de) | 2007-11-22 |
| KR100653590B1 (ko) | 2006-12-04 |
| NZ508996A (en) | 2003-09-26 |
| EP1090924A4 (en) | 2002-07-10 |
| CN1525980A (zh) | 2004-09-01 |
| EP1090924A1 (en) | 2001-04-11 |
| KR20010053180A (ko) | 2001-06-25 |
| AU4392699A (en) | 2000-01-10 |
| CA2331761A1 (en) | 1999-12-29 |
| ID27788A (id) | 2001-04-26 |
| DE69937294T2 (de) | 2008-07-03 |
| EP1090924B1 (en) | 2007-10-10 |
| ES2294844T3 (es) | 2008-04-01 |
| TWI228128B (en) | 2005-02-21 |
| EP1090924B8 (en) | 2007-11-21 |
| WO1999067288A9 (fr) | 2000-03-30 |
| WO1999067288A1 (fr) | 1999-12-29 |
| CN1318447C (zh) | 2007-05-30 |
| JP4413429B2 (ja) | 2010-02-10 |
| US20060008463A1 (en) | 2006-01-12 |
| US7041297B1 (en) | 2006-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1090924B8 (en) | Tumor antigen peptides originating in cyclophilin b | |
| EP2022800A3 (en) | Compositions for the therapy and diagnosis of ovarian cancer | |
| WO1999038973A3 (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
| NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
| WO1999033869A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
| TW581808B (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
| WO1997014806A3 (en) | Delivery of biologically active polypeptides | |
| WO1999047674A3 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
| EP2295453A3 (en) | An appetite-suppressing peptide, its compositions and use | |
| WO2000061612A3 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
| WO1997008318A3 (en) | Compounds and methods for treatment and diagnosis of prostate cancer | |
| IL112664A0 (en) | 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them | |
| IL125590A0 (en) | Peptide immunogens | |
| AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
| WO2000029574A3 (en) | Inflammation-associated genes | |
| EP1571216A3 (en) | Phosphodiesterase 8A | |
| ATE229338T1 (de) | 2',2'-difluornucleoside zur immunosuppressiven therapie und kombinationspräparate | |
| CA2234263A1 (fr) | Composition pharmaceutique contre les tumeurs et infections a papillomavirus | |
| WO1999022722A3 (en) | Use of macrolides for the treatment of cancer and macular degeneration | |
| AU5892399A (en) | 1, 2, 4-triazole-3-thione compounds | |
| WO1997018790A3 (en) | Therapeutic and diagnostic agents for the treatment of microbial infections | |
| NZ510154A (en) | A tumour antigen protein and gene therefor, tumour antigen peptides and derivatives thereof in medicaments and prophylactics | |
| MX9707974A (es) | Derivados de 10, 13, 15-trioxatriciclo [9.2.1.1 9.6]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos. | |
| EP1364657A4 (en) | REMEDIES AGAINST TUMORS AFFECTING HEMATOPOIETIC BODIES | |
| HK1002284A1 (en) | Novel implant and novel vector for the treatment of acquired diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110624 |